Artificial Intelligence

ElevenLabs

Medium2/4 relationships sourcedProfile verified Aug 14, 2026

30-Second Executive Brief

Executive Assessment

ElevenLabs functions as a regional institution within Artificial Intelligence, backed by 55% sourcing coverage, though its relative influence is cooling.

  • Maintains 4 mapped relationships across the graph
  • 55% sourcing coverage across sourced relationships
  • Tracked as regional institution within the Artificial Intelligence category

Executive Snapshot

Strategic Role
Regional Institution
Sourcing Coverage
55%
View Methodology →

Computed live from this entity's own relationships and evidence: how many relationships carry at least one linked citation, weighted with citation recency and source type — independent of Strategic Importance, and not a prediction. Not a hand-typed number; recalculated on every read.

Ecosystem Influence
Moderate
Strategic Momentum
Decelerating

Coverage

Mapped Relationships
4
Technology Domains
4

Strategic Implications

  • Central node connecting multiple strategic ecosystems
  • Directly influences technology and capital flows
  • Material relevance to downstream dependency mapping

Top Opportunities

Continued preparation for a potential IPO within two to three yearsExpanding enterprise adoption across telecom, consulting and financial-services customers

Top Risks

Voice-cloning technology carries acute deepfake and identity-fraud misuse risk requiring ongoing safety and disclosure investmentDoubling valuation via secondary tender offer within months of a primary round raises questions about sustainable public-market pricing

Critical Dependencies

Continue to Dependency Graph ↓

A leading AI voice-cloning and text-to-speech platform used by enterprises including Deutsche Telekom, Boston Consulting Group and Revolut. ElevenLabs raised $500 million from Sequoia Capital, Andreessen Horowitz and Iconiq at an $11 billion valuation in February 2026 -- more than tripling its $3.3 billion valuation from a January 2025 Series C -- reported $500 million in annualized recurring revenue by May 2026, and was in early talks for a secondary tender offer that would value the company at $22 billion by September 2026, as it eyes an eventual IPO.

Sources

Every claim traced to a primary source — evidence, recent activity, and insider filing behavior, all in one place.

Evidence

2 sources

  • CNBCNVIDIA-backed ElevenLabs raises $500M at $11B valuation, eyes IPOnews
  • Briefs / AICertsElevenLabs in talks for $22B tender offer, doubling February valuationnews

Acquisition & Investment Fit

AI-reasoned, generated only from entities already in InsightNodes's own graph — a hypothetical strategic-fit exercise, not real M&A intelligence or a signal that any deal is planned or in progress.

Relationship Map

The relationships surrounding ElevenLabs — ownership, dependencies, regulation, technology and market context. Click any node to make it the new center, 2 levels deep.

Connection type

Sign in free to click a node and explore →

Click any node to make it the new center. Scroll to zoom, drag to pan.

The Story So Far (last 6 months)

May 2026: Reaches $500M ARR, explores $22B tender offerJun 2026: ElevenLabs in talks for $22B tender offer, doubling February valuationAug 2026: A tender offer doubling valuation in months, rather than a new primary round, points to i… (unconfirmed)

Auto-generated from this entity's dated milestones, relationship updates, and sourced evidence — not AI-written, just sorted.

Market Intelligence

Unverified

Credibly-reported claims — analyst notes, sourcing citing “people familiar with the matter,” deals where the companies involved declined to comment — that haven't been officially confirmed. Kept structurally separate from the sourced evidence above; treat as a lead worth researching further, not an established fact.

A tender offer doubling valuation in months, rather than a new primary round, points to insider/employee liquidity demand more than fresh growth capital need

28% confidence

ElevenLabs pursuing a secondary tender offer valuing the company at $22 billion -- double its February 2026 primary round -- rather than a new primary raise, is a structural signal of investor demand and insider liquidity-seeking ahead of a targeted IPO, distinct from a capital-need-driven valuation jump.

This is InsightNodes' own interpretive read: ElevenLabs pursuing a secondary tender offer at $22 billion just months after a primary round at $11 billion (rather than raising a new primary round) typically signals the company doesn't need the cash itself but wants to give early employees and investors liquidity ahead of an IPO -- a healthier signal of investor demand and internal confidence than a distressed or growth-capital-driven raise would be, though the disclosed $500M ARR still needs to be weighed against the $22B price on its own merits.

InsightNodes analysis of ElevenLabs' tender offer structure · Aug 14, 2026

ElevenLabs's Timeline

A sourced, dated history of ElevenLabs's key moments — founding to present.

  1. Jan 2025 · $180M Series C at $3.3B valuation

    ElevenLabs raised a $180 million Series C at a $3.3 billion valuation.

  2. Feb 2026 · Raises $500M at $11B valuation, backed by NVIDIA

    ElevenLabs raised $500 million from Sequoia Capital, Andreessen Horowitz and Iconiq at an $11 billion valuation -- more than tripling its prior $3.3 billion valuation -- with NVIDIA among its backers, as the company eyes an eventual IPO.

  3. May 2026 · Reaches $500M ARR, explores $22B tender offer

    ElevenLabs reported $500 million in annualized recurring revenue with clients including Deutsche Telekom, Boston Consulting Group and Revolut, and entered early talks for a secondary share sale (tender offer) that would value the company at $22 billion -- double its February 2026 funding-round valuation -- expected to be completed by September 2026.